NEFL and myeloid sarcoma: Taken together, our data are in line with prior evidence and reinforce the relevance of NFL, occludin and osteopontin as complementary biomarkers capturing distinct aspects of MS-related neuroinflammation, neuroaxonal damage, and blood–brain barrier dysfunction.